Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 42, 5067-5073, December 1, 1982]
© 1982 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spinelli, W.
Right arrow Articles by Ishii, D. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spinelli, W.
Right arrow Articles by Ishii, D. N.

Effects of Phorbol Ester Tumor Promoters and Nerve Growth Factor on Neurite Outgrowth in Cultured Human Neuroblastoma Cells1

Walter Spinelli2, Kenneth H. Sonnenfeld2,3 and Douglas N. Ishii4

Department of Pharmacology and the Cancer Research Center, College of Physicians and Surgeons of Columbia University, New York, New York 10032

The effect of phorbol ester tumor promoters on neurite outgrowth was studied in cultured human neuroblastoma cell lines and in cultured embryonic chick and neonatal rat sympathetic ganglia. Promoters inhibited nerve growth factor (NGF)-stimulated neurite outgrowth in sympathetic ganglia while nonpromoting structural congeners did not, in keeping with previous results in embryonic sensory ganglia. In contradistinction, promoters reversibly enhanced neurite outgrowth in malignant SH-SY5Y neuroblastoma cells, whereas nonpromoting congeners were inactive. The potent promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) reversibly increased the proportion of SH-SY5Y cells with neurites and the average length of neurites; the effects of the combination of TPA and NGF were greater than that of either compound alone. The half-maximum response to TPA was at about 2 ng/ml (3 nM). The neurites were thinner, straighter, and less branched and showed more swellings resembling beads or varicosities in comparison with NGF-induced neurites. TPA transiently inhibited the cellular growth rate between Days 2 and 4. Thereafter, the rate was the same as in untreated cultures. The transient inhibition was due to causes other than degradation of TPA since fresh TPA was added. The effect of TPA on neurite outgrowth was not transient and was independent of effects on growth. TPA also enhanced neurite outgrowth in another NGF responsive line, LA-N-5, but not in two unresponsive lines, CHP-100 and CHP-134.

1 Supported in part by Grant RO1 NS 14218 from the National Institute of Neurological Communicative Diseases and Stroke.

2 Predoctoral fellow, supported in part by USPHS Training Grant GM 07182 from the Division of General Medical Sciences.

3 Dr. and Mrs. S. C. Wang Predoctoral Fellow. Present address: Department of Physiological Chemistry and Pharmacology, Roche Institute of Molecular Biology, Nutley, N. J. 07110.

4 Recipient of USPHS Research Career Development Award 1K04 NS 00375. To whom requests for reprints should be addressed.

Received 3/22/82. Accepted 8/18/82.




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
C. Cetinkaya, A. Hultquist, Y. Su, S. Wu, F. Bahram, S. Pahlman, I. Guzhova, and L.-G. Larsson
Combined IFN-{gamma} and retinoic acid treatment targets the N-Myc/Max/Mad1 network resulting in repression of N-Myc target genes in MYCN-amplified neuroblastoma cells
Mol. Cancer Ther., October 1, 2007; 6(10): 2634 - 2641.
[Abstract] [Full Text] [PDF]


Home page
GENES CELLSHome page
S. Kawa, J. Fujimoto, T. Tezuka, T. Nakazawa, and T. Yamamoto
Involvement of BREK, a serine/threonine kinase enriched in brain, in NGF signalling
Genes Cells, March 1, 2004; 9(3): 219 - 232.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Missale, A. Codignola, S. Sigala, A. Finardi, M. Paez-Pereda, E. Sher, and P. Spano
Nerve growth factor abrogates the tumorigenicity of human small cell lung cancer cell lines
PNAS, April 28, 1998; 95(9): 5366 - 5371.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Hundle, T. McMahon, J. Dadgar, C.-H. Chen, D. Mochly-Rosen, and R. O. Messing
An Inhibitory Fragment Derived from Protein Kinase Cepsilon Prevents Enhancement of Nerve Growth Factor Responses by Ethanol and Phorbol Esters
J. Biol. Chem., June 6, 1997; 272(23): 15028 - 15035.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Hundle, T. McMahon, J. Dadgar, and R. O. Messing
Overexpression of [IMAGE]-Protein Kinase C Enhances Nerve Growth Factor-induced Phosphorylation of Mitogen-activated Protein Kinases and Neurite Outgrowth
J. Biol. Chem., December 15, 1995; 270(50): 30134 - 30140.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1982 by the American Association for Cancer Research.